Evidence map›Paper›PMID 21907348›Full record

Trial reportThe Journal of pediatrics2012

Inhaled nitric oxide therapy increases blood nitrite, nitrate, and s-nitrosohemoglobin concentrations in infants with pulmonary hypertension.

Yomna I Ibrahim, Janet R Ninnis, Andrew O Hopper, Douglas D Deming, Amy X Zhang, Jason L Herring, Lawrence C Sowers, Timothy J McMahon, Gordon G Power, Arlin B Blood

Abstract readClinical Trial
In one paragraph

Trial report in The Journal of pediatrics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. The role of gasotransmitters in neonatal physiology.Nitric oxide : biology and chemistry · 2020
    Review
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Treatment-related biomarkers in pulmonary hypertension.American journal of respiratory cell and molecular biology · 2015
    Review
  14. Review
  15. Article
  16. Oxidative Stress and Therapeutic Development in Lung Diseases.Journal of pulmonary & respiratory medicine · 2014
    Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Yomna I IbrahimDepartment of Pediatrics, Division of Neonatology, School of Medicine, Loma Linda University, Loma Linda, CA, USA.
Janet R Ninnis
Andrew O Hopper
Douglas D Deming
Amy X Zhang
Jason L Herring
Lawrence C Sowers
Timothy J McMahon
Gordon G Power
Arlin B Blood
Loma Linda University · USDuke University · US

Funding

Role of nitrite and hemoglobin in vascular NO homeostasis in the fetus and adultR01HL095973 · NHLBI · LOMA LINDA UNIVERSITY · PI BLOOD, ARLIN B · 2009 to 2013
$1.9M
Mechanistic basis of lung dysfunction after RBC transfusionI01BX000281 · VA · DURHAM VA MEDICAL CENTER · PI MCMAHON, TIMOTHY J · 2009 to 2014
–
BLRD VA I01 BX000281NHLBI NIH HHS HL095973NHLBI NIH HHS R01 HL095973
6 · The paper itself

Abstract

objectiveTo measure the circulating concentrations of nitric oxide (NO) adducts with NO bioactivity after inhaled NO (iNO) therapy in infants with pulmonary hypertension. STUDY

designIn this single center study, 5 sequential blood samples were collected from infants with pulmonary hypertension before, during, and after therapy with iNO (n = 17). Samples were collected from a control group of hospitalized infants without pulmonary hypertension (n = 16) and from healthy adults for comparison (n = 12).

resultsAfter beginning iNO (20 ppm) whole blood nitrite levels increased approximately two-fold within 2 hours (P<.01). Whole blood nitrate levels increased to 4-fold higher than baseline during treatment with 20 ppm iNO (P<.01). S-nitrosohemoglobin increased measurably after beginning iNO (P<.01), whereas iron nitrosyl hemoglobin and total hemoglobin-bound NO-species compounds did not change.

conclusionTreatment of pulmonary hypertensive infants with iNO results in increases in levels of nitrite, nitrate, and S-nitrosohemoglobin in circulating blood. We speculate that these compounds may be carriers of NO bioactivity throughout the body and account for peripheral effects of iNO in the brain, heart, and other organs.

Indexed as

Administration, InhalationAdultFemaleHemoglobinsHumansHypertension, PulmonaryInfantInfant, NewbornMaleNitratesNitric OxideNitritesTreatment OutcomeVasodilator AgentsHemoglobinsNitratesNitric OxideNitritesS-nitrosohemoglobinVasodilator Agents

Identifiers

PMID21907348
PMCPMC3237823
OpenAlexW2009383132

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.